Health sciences

Pfizer and Moderna expect Data on Vaccine Protection against New Covid Variant Soon

Biontech says it expects to have more data within two weeks to help determine whether the coronavirus vaccine, which it co-developed with Pfizer, needs to be reworked because of a new version of the coronavirus discovered in South Africa.

Pfizer and Biontech have said they expect to be able to deliver a possible new vaccine made for the new version in about 100 days, if necessary.

The Anti-Covid “Merck” Pill turns out as not very Effective

Updated data from the experimental pill for the treatment of COVID-19 by the American company Merck & Co show that its effectiveness is significantly lower than the original report. According to preliminary data from October, "molnupiravir" reduces the risk of death and hospitalization by 50%.

Pfizer Vaccine is Now Recommended for Children aged 5 to 11

The Commission for Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EDA) has recommended that the use of the Comirnaty vaccine by Biontech / Pfizer against COVID-19 be given to children aged 5 to 11 years.

The vaccine is already used on children that are 12 years old.

Gaga: Three times as many COVID-19 infections as last year, less hospitalisation

With Greek hospitals in various regions at the breaking point, Alternate Health Minister Mina Gaga has again issued an urgent plea for people to get the COVID-19 jab - both for the first time and the third, booster shot - and underlined that the pandemic now hits mainly unvaccinated people.

Minister calls for coordinated action to accelerate jab drive

Turkey's health minister has called for a common and coordinated action in order to accelerate vaccinations against COVID-19.

"We are expecting support from the healthcare community to help overcome vaccine hesitancy and from all media outlets to reach out to the public and get messages regarding the vaccination across," Fahrettin Koca said.

Pages